Polyamine-dependent regulation of Vibrio cholerae biofilm formation
霍乱弧菌生物膜形成的多胺依赖性调节
基本信息
- 批准号:8179979
- 负责人:
- 金额:$ 39.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-17 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAttentionBacteriaBindingBinding ProteinsBiological AssayCalorimetryCellsCessation of lifeChemicalsCholeraDesiccationDevelopmentDiseaseDisease ProgressionEngineeringEnvironmentEnzymesEpitopesEventGenesGoalsHigh Pressure Liquid ChromatographyHost Defense MechanismHumanImmuneIn VitroInfectionIntegral Membrane ProteinIntestinesLeadLife StyleLigandsMediatingMembrane ProteinsMicrobial BiofilmsModelingOrganismOryctolagus cuniculusPeriplasmic ProteinsPolyaminesProcessProtein FamilyProtein Sequence AnalysisProteinsReactionReading FramesRegulationReportingRoleSignal TransductionSpermidineStomachStressSurfaceSurvivorsSystemTestingTitrationsUltraviolet RaysVibrio choleraeVibrio cholerae O139WorkWorld Health Organizationantimicrobialbasebis(3&apos,5&apos)-cyclic diguanylic acidcarbenecombatdesignextracellularinsightmembermicrobial communitymutantnorspermidinenovel strategiesperiplasmphosphoric diester hydrolaseresearch studysensorsolutesugar
项目摘要
DESCRIPTION (provided by applicant): Vibrio cholerae is the causative agent of the devastating diarrheal disease cholera. This organism is also a natural inhabitant of aquatic environments worldwide. V. cholerae is thought to exist in these environments primarily in microbial communities called biofilms. Biofilm bacteria are more tolerant to environmental stresses such as UV radiation, desiccation, low pH, antimicrobials, and the immune defenses of the human host. This tolerance protects V. cholerae not only from the harsh conditions in the environment, but also from the acidic conditions of the host stomach. There is also evidence of V. cholerae biofilms in the host intestinal environment, which suggests that V. cholerae might use biofilm formation as a long-term protective strategy in the human host. Development of biofilms is controlled by signaling networks that respond to chemical signals in the environment. Our long-term goal is to identify and understand the signaling systems that regulate biofilm formation in V. cholerae. In this proposal, we focus our attention on a specific signaling system that responds to the polyamines norspermidine and spermidine. These polyamines are thought to act as environmental signals that are detected and processed by a signaling system composed of the proteins NspS and MbaA. NspS is predicted to be the sensor protein or the system that detects these polyamines. MbaA is predicted to be a phosphodiesterase that breaks down cyclic-diguanylate-monophosphate (c-di-GMP), one of the central modulators of biofilm formation in V. cholerae. We hypothesize that norspermidine and spermidine bind directly to NspS; these binding events affect the interaction of NspS and MbaA, which then results in changes in its c-di-GMP phosphodiesterase activity. This change is manifested as increases or decreases in c-di-GMP levels in the cell that lead to corresponding increases or decreases in biofilm formation. We base this hypothesis on the following observations: 1) NspS is homologous to the spermidine binding protein PotD of Esherichia coli; 2) In the absence of NspS and MbaA, spermidine and norspermidine cannot affect biofilm formation when supplied extracellularly; 3) MbaA contains an EAL domain, found in c-di- GMP phophodiesterases, in which all the residues that contribute to enzymatic activity are conserved. The goal of the proposed project is to provide definitive evidence for this signaling system. The specific aims of this project are to i) Establish that norspermidine and spermidine are ligands for NspS by doing binding experiments using isothermal titration calorimetry; ii) Provide evidence for NspS-MbaA interaction using coimmunoprecipitation experiments; and iii) Confirm that MbaA is a phosphodiesterase by enzyme assays and correlate this activity to its role in biofilm formation using biofilm assays.
PUBLIC HEALTH RELEVANCE: Vibrio cholerae is the causative agent of the devastating diarrhoeal disease cholera. According to the World Health Organization, cholera is estimated to result in approximately 100,000 deaths worldwide every year. V. cholerae can exist in the human host in microbial communities called biofilms, which can make this organism highly tolerant to host defense mechanisms and potentially aid in disease progression (Hang et al., 2003, Xu et al., 2003). The insight gained from the proposed project, which involves studying V. cholerae biofilm formation, is expected to provide a better understanding of cholera and yield novel strategies to combat this deadly disease.
描述(由申请人提供):霍乱弧菌是毁灭性腹泻病霍乱的病原体。这种生物也是全世界水生环境的天然居民。人们认为霍乱弧菌主要存在于这些环境中称为生物膜的微生物群落中。生物膜细菌对环境压力(例如紫外线辐射、干燥、低pH值、抗菌剂和人类宿主的免疫防御)具有更强的耐受性。这种耐受性不仅可以保护霍乱弧菌免受环境中恶劣条件的影响,还可以使其免受宿主胃部酸性条件的影响。还有证据表明宿主肠道环境中存在霍乱弧菌生物膜,这表明霍乱弧菌可能利用生物膜形成作为人类宿主的长期保护策略。生物膜的形成是由响应环境中化学信号的信号网络控制的。我们的长期目标是识别和了解调节霍乱弧菌生物膜形成的信号系统。在本提案中,我们将注意力集中在对多胺去甲亚精胺和亚精胺作出反应的特定信号系统上。这些多胺被认为充当环境信号,由蛋白质 NspS 和 MbaA 组成的信号系统检测和处理。 NspS 预计是传感器蛋白或检测这些多胺的系统。 MbaA 预计是一种磷酸二酯酶,可分解环二鸟苷酸单磷酸 (c-di-GMP),环二鸟苷酸是霍乱弧菌生物膜形成的主要调节剂之一。我们假设去甲亚精胺和亚精胺直接与 NspS 结合;这些结合事件影响 NspS 和 MbaA 的相互作用,从而导致其 c-di-GMP 磷酸二酯酶活性发生变化。这种变化表现为细胞中 c-di-GMP 水平的增加或减少,从而导致生物膜形成相应增加或减少。我们的这一假设基于以下观察:1)NspS 与大肠杆菌的亚精胺结合蛋白 PotD 同源; 2) 在缺乏NspS和MbaA的情况下,亚精胺和去甲亚精胺在细胞外提供时不能影响生物膜的形成; 3) MbaA 含有一个 EAL 结构域,存在于 c-di-GMP 磷酸二酯酶中,其中所有有助于酶活性的残基都是保守的。拟议项目的目标是为该信号系统提供明确的证据。该项目的具体目标是 i) 通过使用等温滴定量热法进行结合实验,确定去甲亚精胺和亚精胺是 NspS 的配体; ii) 使用免疫共沉淀实验提供 NspS-MbaA 相互作用的证据; iii) 通过酶测定确认 MbaA 是一种磷酸二酯酶,并使用生物膜测定将该活性与其在生物膜形成中的作用相关联。
公共卫生相关性:霍乱弧菌是毁灭性腹泻病霍乱的病原体。据世界卫生组织估计,霍乱每年导致全球约 10 万人死亡。霍乱弧菌可以存在于人类宿主中称为生物膜的微生物群落中,这可以使该生物体对宿主防御机制具有高度耐受性,并可能有助于疾病进展(Hang 等人,2003 年;Xu 等人,2003 年)。该项目涉及研究霍乱弧菌生物膜的形成,从中获得的见解预计将有助于更好地了解霍乱,并产生对抗这种致命疾病的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ece Karatan其他文献
Ece Karatan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 39.56万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 39.56万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 39.56万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 39.56万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 39.56万 - 项目类别:














{{item.name}}会员




